First cancer vaccine approved for women

Women now have the option of being immunized against cervical cancer following approval of Merck's Gardasil. Gardasil is a quadrivalent vaccine prepared from human papillomavirus (HPV) proteins. It provides 100% protection against HPV types 15 and 18 - the virus types that cause approximately 7...

Full description

Saved in:
Bibliographic Details
Published in:Drug Topics 2006-07, Vol.150 (14), p.13
Main Author: Karpa, Kelly Dowhower
Format: Magazinearticle
Language:English
Subjects:
Cancer vaccines
Cervical cancer
FDA approval
Human papillomavirus
Licensing, certification and accreditation
Pharmaceutical industry
Product development
Vaccines
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Women now have the option of being immunized against cervical cancer following approval of Merck's Gardasil. Gardasil is a quadrivalent vaccine prepared from human papillomavirus (HPV) proteins. It provides 100% protection against HPV types 15 and 18 - the virus types that cause approximately 70% of cervical cancers) and 99% protection against HPV types 6 and 11 (these types cause approximately 90% of genital warts. It is approved for use in women and girls between the agens of 9 and 25 years for the prevention of cervical cancer, genital warts and precancerous lesions.
ISSN:0012-6616
1937-8157